We are a drug development company dedicated to pioneering innovative therapies for sexual dysfunction in both men and women-offering new hope where existing options fall short or don’t exist.

We have completed Phase II of clinical trials for men and are about to complete it for women too. Our key drug is a new chemical entity called BZ371A.

BZ371A represents a groundbreaking innovation in sexual health therapy. This synthetic non-hormonal peptide is derived from the venom of the Phoneutria nigriventer spider, known for causing powerful priapism in bite victims.

Unlike conventional treatments, BZ371A works through a novel pathway by directly activating iNOS and nNOS enzymes, triggering Nitric Oxide production without requiring neurogenic stimulation. This cascade leads to cGMP synthesis, promoting soft muscle relaxation and increased blood flow even in the absence of sexual stimulation. This unique mechanism makes BZ371A particularly valuable for individuals whose neural pathways have been compromised, such as those who have undergone prostatectomy, or for women experience HSDD (or low libido and desire).

We are dedicated to restoring hope and intimacy for millions affected by sexual health challenges. For those who find current treatments ineffective-whether due to prostate surgery, standard drug limitations, or persistent low desire-our innovative, non-hormonal topical peptide offers a new solution. Our mission is to empower men and women to reclaim their confidence, improve their quality of life, and reconnect with their partners. We believe everyone deserves the opportunity to experience fulfilling relationships and renewed joy.


Another Day Pharma

Org chart

Teams

Offices

Another Day Pharma

Org chart

Teams

Offices

Related companies